NCAM1 and schizophrenia: One meta-analysis shows an increase in both relative and absolute levels of CD56+ cells in patients with schizophrenia. However, there are case-control studies that suggest that the number of NK cells in patients with schizophrenia does not differ from healthy donors or even significantly lower.